1. Home
  2. QBTS vs MDGL Comparison

QBTS vs MDGL Comparison

Compare QBTS & MDGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo D-Wave Quantum Inc.

QBTS

D-Wave Quantum Inc.

HOLD

Current Price

$24.27

Market Cap

9.7B

Sector

Technology

ML Signal

HOLD

Logo Madrigal Pharmaceuticals Inc.

MDGL

Madrigal Pharmaceuticals Inc.

HOLD

Current Price

$503.93

Market Cap

11.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
QBTS
MDGL
Founded
1999
2011
Country
United States
United States
Employees
388
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.7B
11.1B
IPO Year
N/A
2005

Fundamental Metrics

Financial Performance
Metric
QBTS
MDGL
Price
$24.27
$503.93
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
15
12
Target Price
$32.53
$674.45
AVG Volume (30 Days)
39.7M
245.0K
Earning Date
05-12-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
41.32
EPS
N/A
N/A
Revenue
N/A
$180,133,000.00
Revenue This Year
$81.05
$58.39
Revenue Next Year
$93.13
$48.55
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$12.75
$279.33
52 Week High
$46.75
$615.00

Technical Indicators

Market Signals
Indicator
QBTS
MDGL
Relative Strength Index (RSI) 49.74 52.28
Support Level $23.20 $498.59
Resistance Level $24.78 $502.97
Average True Range (ATR) 2.40 19.92
MACD -0.54 2.65
Stochastic Oscillator 20.00 86.62

Price Performance

Historical Comparison
QBTS
MDGL

About QBTS D-Wave Quantum Inc.

D-Wave Quantum Inc is in the development and delivery of quantum computing systems, software, and services, and it is the commercial supplier of quantum computers and the only company building both annealing quantum computers and gate-model quantum computers. It delivers customer value with practical quantum applications for problems as diverse as logistics, artificial intelligence, materials sciences, drug discovery, scheduling, cybersecurity, fault detection, and financial modeling. Its annealing quantum computers are accessible through the company's LeapTM cloud service.

About MDGL Madrigal Pharmaceuticals Inc.

Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, liver cancer, need for liver transplantation and premature mortality. Its medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor beta agonist designed to target key underlying causes of MASH.

Share on Social Networks: